|
CIRH1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.281950E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.460830E-01 |
| Normal-vs-Stage2 |
2.857600E-01 |
| Normal-vs-Stage3 |
1.176560E-01 |
| Normal-vs-Stage4 |
8.000600E-01 |
| Stage1-vs-Stage2 |
9.424400E-01 |
| Stage1-vs-Stage3 |
3.559000E-01 |
| Stage1-vs-Stage4 |
3.595000E-01 |
| Stage2-vs-Stage3 |
4.513000E-01 |
| Stage2-vs-Stage4 |
3.422400E-01 |
| Stage3-vs-Stage4 |
1.216040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.648990E-01 |
| Normal-vs-AfricanAmerican |
5.925800E-01 |
| Normal-vs-Asian |
5.177000E-01 |
| Caucasian-vs-AfricanAmerican |
2.939400E-01 |
| Caucasian-vs-Asian |
6.242000E-01 |
| AfricanAmerican-vs-Asian |
5.605000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.382210E-01 |
| Normal-vs-Female |
2.141200E-01 |
| Male-vs-Female |
9.745200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.518800E-01 |
| Normal-vs-Extreme_Weight |
5.476400E-01 |
| Normal-vs-Obese |
4.962600E-01 |
| Normal-vs-Extreme_Obese |
1.366240E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.112600E-01 |
| Normal_Weight-vs-Obese |
9.496200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.072810E-01 |
| Extreme_Weight-vs-Obese |
8.338000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.873190E-01 |
| Obese-vs-Extreme_Obese |
2.109800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.571800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.737400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.591190E-01 |
| Normal-vs-Age(81-100Yrs) |
1.485770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.721400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.597800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.582600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.204200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.902250E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.814800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.440200E-01 |
| Normal-VS-Type2 PRCC |
3.620000E-03 |
| Normal-VS-KIRP CIMP |
3.239400E-01 |
| Normal-VS-Unclassified PRCC |
3.188500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.880600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.836210E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.100100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.584100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.880800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.970350E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.953800E-02 |
| Normal-vs-N1 |
2.952800E-01 |
| Normal-vs-N2 |
3.094200E-02 |
| N0-vs-N1 |
3.128600E-01 |
| N0-vs-N2 |
1.165750E-04 |
| N1-vs-N2 |
6.303900E-03 |
|
|
